Schedule-dependent toxicity of tumor necrosis factor in rodents.

Cancer Drug Deliv

Arizona Cancer Center, University of Arizona, Department of Pharmacology, Tucson 85724.

Published: July 1988

The effect of recombinant human tumor necrosis factor-alpha (rhTNF-alpha) on rodent hematopoietic precursors and hepatocytes was evaluated. rhTNF-alpha appears to have minimal toxic effects on isolated hepatocytes and on granulocyte-macrophage colony-forming units (CFU-GM) in vitro. It does, however, show a dose- and schedule-dependent inhibition of pluripotent bone marrow stem cells in mice. This was most evident with prolonged continuous infusion schedules. In contrast, single daily injections of rhTNF-alpha did not depress bone marrow or peripheral blood counts, although slight elevations in hepatic enzyme levels were apparent. These studies suggest that continuous infusions of rhTNF-alpha in man may produce enhanced bone marrow suppression over equivalent bolus doses.

Download full-text PDF

Source
http://dx.doi.org/10.1089/cdd.1987.4.159DOI Listing

Publication Analysis

Top Keywords

bone marrow
12
tumor necrosis
8
schedule-dependent toxicity
4
toxicity tumor
4
necrosis factor
4
factor rodents
4
rodents recombinant
4
recombinant human
4
human tumor
4
necrosis factor-alpha
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!